These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18056831)

  • 1. Buspirone for autistic disorder in a woman with an intellectual disability.
    Brahm NC; Fast GA; Brown RC
    Ann Pharmacother; 2008 Jan; 42(1):131-7. PubMed ID: 18056831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons.
    Ratey JJ; Sovner R; Mikkelsen E; Chmielinski HE
    J Clin Psychiatry; 1989 Oct; 50(10):382-4. PubMed ID: 2793836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: a naturalistic study.
    Capone GT; Goyal P; Grados M; Smith B; Kammann H
    J Dev Behav Pediatr; 2008 Apr; 29(2):106-16. PubMed ID: 18349709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of buspirone on challenging behaviour in mentally retarded patients: an open prospective multiple-case study.
    Verhoeven WM; Tuinier S
    J Intellect Disabil Res; 1996 Dec; 40 ( Pt 6)():502-8. PubMed ID: 9004110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy in autism.
    Frischauf E
    J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):577. PubMed ID: 9136488
    [No Abstract]   [Full Text] [Related]  

  • 6. Antipsychotic dose-sparing effect with addition of memantine.
    Sleeper RB
    Ann Pharmacother; 2005 Sep; 39(9):1573-6. PubMed ID: 16076907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects of naltrexone on autistic behavior.
    Zingarelli G; Ellman G; Hom A; Wymore M; Heidorn S; Chicz-DeMet A
    Am J Ment Retard; 1992 Jul; 97(1):57-63. PubMed ID: 1497864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of buspirone with aggressive behavior.
    Hillbrand M; Scott K
    J Autism Dev Disord; 1995 Dec; 25(6):663-4. PubMed ID: 8720034
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical effects of buspirone on intractable self-injury in adults with mental retardation.
    Ricketts RW; Goza AB; Ellis CR; Singh YN; Chambers S; Singh NN; Cooke JC
    J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):270-6. PubMed ID: 8150800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buspirone's efficacy in organic-induced aggression.
    Stanislav SW; Fabre T; Crismon ML; Childs A
    J Clin Psychopharmacol; 1994 Apr; 14(2):126-30. PubMed ID: 8195453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone: a potential treatment for autism.
    Posey DJ; McDougle CJ
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1212-6. PubMed ID: 12211417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
    Adler BA; Wink LK; Early M; Shaffer R; Minshawi N; McDougle CJ; Erickson CA
    Autism; 2015 Jan; 19(1):102-6. PubMed ID: 24571823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Cobaugh DJ; Erdman AR; Booze LL; Scharman EJ; Christianson G; Manoguerra AS; Caravati EM; Chyka PA; Woolf AD; Nelson LS; Troutman WG
    Clin Toxicol (Phila); 2007 Dec; 45(8):918-42. PubMed ID: 18163235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study.
    Ratey J; Sovner R; Parks A; Rogentine K
    J Clin Psychiatry; 1991 Apr; 52(4):159-62. PubMed ID: 2016248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia.
    Kopecek M; Bares M; Horacek J; Mohr P
    Neuro Endocrinol Lett; 2006 Dec; 27(6):803-6. PubMed ID: 17187006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of clozapine in a mentally retarded and aggressive population.
    Cohen SA; Underwood MT
    J Clin Psychiatry; 1994 Oct; 55(10):440-4. PubMed ID: 7961521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone-induced double incontinence.
    Hergüner S; Mukaddes NM
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1085-6. PubMed ID: 18387724
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of Snoezelen room, Activities of Daily Living skills training, and Vocational skills training on aggression and self-injury by adults with mental retardation and mental illness.
    Singh NN; Lancioni GE; Winton AS; Molina EJ; Sage M; Brown S; Groeneweg J
    Res Dev Disabil; 2004; 25(3):285-93. PubMed ID: 15134793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buspirone for stereotypic movements in elderly with cognitive impairment.
    Helvink B; Holroyd S
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):242-4. PubMed ID: 16720804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.